Growth Flags
show if company had growth for consecutive years
| Dec '21 | Dec '22 | Dec '23 | |
|---|---|---|---|
Current Ratio |
0.59 | 0.38 | 0.04 |
Net Debt/EBITDA |
0.35 | 0.10 | 0.01 |
Debt/Assets |
0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.21 | 0.15 |
Operating CF/Net income |
0.48 | 0.48 | 0.37 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| 0.00% | 306.68% | 250.73% | |
| 0.00% | (175.69%) | (197.92%) | |
ROIC |
0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
296.02% | 243.17% | 115.43% |
Average Days of Receivables |
1,900.96 | 543.52 | 146.09 |
Research and Development Expense of Revenue |
233.74% | 137.60% | 195.40% |
Selling, General and Administrative Expense of Revenue |
1,655.90% | 594.21% | 828.72% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.80 |
Share Based Compensation of Revenue |
654.64% | 173.81% | 88.40% |
Graham Number |
0.00 | 2.45 | 1.88 |
Free Cash Flow per Share |
(0.69) | (0.46) | (0.23) |
Cash per Share |
0.36 | 0.07 | 0.00 |
Shareholders Equity per Share |
(0.43) | (0.28) | (0.26) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
(0.43) | (0.28) | (0.26) |
Free Cash Flow |
(6.48) | (5.29) | (3.27) |
Working Capital |
(4.56) | (4.57) | (7.56) |
Capital Expenditures |
— | 0.00 | — |
Net Current Asset Value |
(5.61) | (4.94) | (7.65) |
| Other line items | |||
Quick Ratio |
0.59 | 0.37 | 0.04 |
Depreciation/Fixed assets |
422.29 | 398.23 | 679.59 |
Cash ROIC |
1,025.67% | 217.09% | 89.03% |
Accounts Receivable Turnover |
0.00 | 0.52 | 0.59 |
Accounts Payable Turnover |
0.00 | 0.26 | 0.17 |
Inventory Turnover |
0.00 | 0.00 | 0.00 |
Average Days of Payables |
1,866.58 | 1,494.51 | 2,292.15 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 |
Revenue per Share |
0.06 | 0.11 | 0.05 |
Operating CF per Share |
(0.69) | (0.46) | (0.23) |
Capex per Share |
0.00 | 0.00 | 0.00 |
Average Receivables |
— | 2.53 | 1.12 |
Average Payables |
— | 4.48 | 5.08 |
Average Assets |
— | 6.33 | 4.41 |
Average Common Equity |
— | (3.62) | (3.48) |
Capex to Sales |
0.00 | 0.00 | 0.00 |
Net Profit Margin |
(2,272.87%) | (839.25%) | (1,329.81%) |
Columns are period end dates